Liste des publications scientifiques de Laurent RIVIER
1. L. Rivier et P.E. Pilet (1971) Composés hallucinogènes indoliques naturels. Année Biologique10, 129-149.
2. L. Rivier and J.E. Lindgren (1972) Ayahuasca, the south-american hallucinogenic
drink - an ethnobotanical and chemical investigation. Economic Botany26, 101-129.
3. L. Rivier and P.E. Pilet (1974) Indolyl-3-acetic acid in cap and apex of maize roots :
identification and quantification by mass fragmentography. Planta (Berlin) 120, 107- 112.
4. L. Rivier et P. Baumann (1976) La spectrométrie de masse en biologie et médecine. Bulletin de la Société vaudoise des sciences naturelles349, 1-18.
5. L. Rivier, H. Milon and P.E. Pilet (1977) Gas-chromatography mass-spectrometric
determinations of abscisic acid levels in the cap and the apex of maize roots. Planta (Berlin) 134, 23-27.
6. B. Holmstedt, J.E. Lindgren, L. Rivier and R.E. Schultes (1977) De plantis toxicariis e
mundo novo tropicale commentationes XVII : Phytochemical examination of Spruce's ethnobotanical collection of Anadenanthera peregrina. Botanical Museum Leaflets Harvard University25, 273-287.
7. R.E. Schultes, M.S. Blum, J.W. Daly, H.M. Fales, B. Holmstedt, D.M. Jerina, J.E.
Lindgren, C.W. Myers, T.C. Plowman, L. Rivier, T. Swain, O. Tovar, G.H.N. Towers and J.W. Wheeler (1977) Ethnopharmacological studies of the flora and fauna of the Pebas region of the peruvian amazon. R/V Alpha Helix Activity Report , National Science Foundation, p. 16.
8. B. Holmstedt, J.E. Lindgren, L. Rivier and T. Plowman (1979) Cocaine in blood of
coca chewers. Botanical Museum Leaflets Harvard University26, 199-201.
9. L. Rivier and J.G. Bruhn (1979) Editorial. Journal of Ethnopharmacology1, 1-2.
10. B. Holmstedt, J.E. Lindgren, L. Rivier and T. Plowman (1979) Cocaine in blood of
coca chewers. Journal of Ethnopharmacology1, 69-78.
11. B. Holmstedt, J.E. Lindgren, L. Rivier and J. Ribeiro do Valle (1979) Ayahuasca, caapi
o yagê - bebida alucinogena dos indios da bacia amazonica. Ciencia e Cultura31, 1120-1124.
12. P.E. Pilet and L. Rivier (1980) Light and dark georeaction of maize roots : effect and
endogenous levels of abscisic acid. Plant Science Letters 18, 201-206.
13. B. Holmstedt, J.E. Lindgren, L. Rivier, R.E. Schultes, T. Plowman and O. Towar
(1980) Indole alkaloids in amazonian myristicaceae : field and laboratory research. Botanical Museum Leaflets Harvard University28, 215-234.
14. L. Rivier and P.E. Pilet (1981) ABA levels in the root tips of seven Zea mays varieties. Phytochemistry20, 17-19.
15. L. Rivier, P. Gaskin, K.-Y. S. Albone and J. MacMillan (1981) GC-MS identification
of endogenous gibberellins and gibberellin-conjugates as their permethylated derivatives. Phytochemistry20, 687-692.
16. L. Rivier (1981) Introduction to a special issue on coca and cocaine. Journal of Ethnopharmacology3, 111-112.
17. L. Rivier (1981) Analysis of alkaloids in leaves of cultivated Erythroxylum and
characterization of alkaline substances used during coca chewing. Journal of Ethnopharmacology3, 313-335.
18. P.E. Pilet and L. Rivier (1981) Abscisic acid distribution in horizontal maize root
segments. Planta (Berlin) 153, 453-458.
19. M.S. Blum, L. Rivier and T. Plowman (1981) Fate of cocaine in the lymantriid Eloria
noyesi, a predator of Erythroxylum coca. Phytochemistry20, 2499-2500.
20. J.R.F. Allen, L. Rivier and P.E. Pilet (1982) Quantification of indol-3yl-acetic acid in
pea and maize seedlings by gas chromatography-mass spectrometry. Phytochemistry 21, 525-530.
21. J.R.F. Allen, J.E. Rebeaud, L. Rivier and P.E. Pilet (1982) Quantification of indol-3yl-
acetic acid by GC-MS using deuterated labelled internal standards. In "Stable Isotopes", H.L. Schmidt, K. Heinzinger and H. Foerstel (Edts.) Analytical Chemistry Symposia Serie Vol. 11, Elsevier : Amsterdam, 529-534.
22. L. Rivier and P.E. Pilet (1982) Quantitation of abscisic acid and its 2-trans isomer in
plant tissues using a stable isotope dilution technique. In "Stable Isotopes", H.L. Schmidt, K. Heinzinger and H. Foerstel (Edts.) Analytical Chemistry Symposia Serie Vol. 11, Elsevier : Amsterdam, 535-541.
23. P. Baumann, L. Koeb, D. Tinguely and L. Rivier (1982) A method for the analysis of
free, total plasma and saliva amitriptyline and nortriptyline by dialysis and GC-MS. European Journal of Mass Spectrometry2, 19-26.
24. M.J. Balik, L. Rivier and T. Plowman (1982) The effect of field preservation on
alkaloid content of fresh coca leaves ( Erythroxylum spp.). Journal of Ethnopharmacology6, 287-291.
25. L. Rivier (1982) Une nouvelle technique de dosage biochimique : la GC-MS, progrès et
quelques réflexions critiques. Dialectica36, 23-28.
26. P. Baumann, L. Rivier and M. Perey (1983) Assay of tryptophan and related
compounds as norharman derivatives by GC-MS in plasma. In "Recent Developments in Mass Spectrometry in Biochemistry, Medicine and Environmental Research ", A. Frigerio, edt. Vol. 8, Elsevier : Amsterdam, 185-190.
27. L. Rivier and P.E. Pilet (1983) Simultaneous gas chromatographic-mass spectrometry :
determination of abscisic acid and indol-3yl-acetic acid in the same plant tissue using 2H-labelled internal standard. In "Recent Developments in Mass Spectrometry in Biochemistry, Medicine and Environmental Research ", A. Frigerio (Edt.) Vol. 8, Elsevier : Amsterdam, 219-231.
28. T. Plowman and L. Rivier (1983) Analyses of cocaine and cinnamoylcocaine in 31
Erythroxylum species. Annals of Botany51, 641-659.
29. L. Rivier, J.F. Léonard and J.P. Cottier (1983) Rapid effect of osmotic stress on the
content and exodiffusion of ABA in Zea mays roots. Plant Science Letters 31, 133- 137.
30. P. Baumann, L. Koeb and L. Rivier (1984) Beta-carboline levels in blood of smokers
and non-smokers. In "Progress in Tryptophan and Serotonin Research ". H.G. Schlossberger, W. Kochen, B. Linzen and H. Steinhart (Edts.) De Gruyter : Berlin, 491-501.
31. L. Rivier and J.G. Bruhn (1985) Editorial. Journal of Ethnopharmacology13, 1.
32. P.A.G.M. de Smet and L. Rivier (1985) Intoxicating snuffs of the Venezuelan Piaroa
indians. Journal of Psychoactive Drugs, 17, 93-103.
33. J. Davies, E. Jensen, O. Junttila, L. Rivier et A. Crozier (1985) Identification of
Endogenous gibberellins from Salix pentandra . Plant Physiology, 78, 473-476 .
34. L. Rivier and M. Saugy (1986) Chemical Ionization Mass Spectrometry of Indol-3yl-
Acetic Acid and Cis-Abscisic Acid : evaluation of negative ions detection and quantification of Cis-Abscisic Acid in growing maize roots. Journal of Plant Growth Regulation, 5, 1-16 .
35. L. Rivier (1986) GC-MS of auxins. In "Gas Chromatography/Mass Spectrometry".Modern Methods in Plant Analysis New Serie Vol. 3. H.-F. Linskens and J.F. Jackson (Edts.) Springer : Heidelberg, 146-188 .
36. E. Jensen, L. Rivier, O. Junttila and A. Crozier (1986) Identification of Abscisic acid
from shoots of Salix pentandra, Physiologia Plantarum,66, 406-408.
37. L. Rivier, J.G. Bruhn, M. Malone and T. Plowman (1986) Editorial : Creation of the
International Society for Ethnopharmacology (ISEP), Journal of Ethnopharmacology 18, 1.
38. L. Rivier and A. Crozier, Editors (1987) Principles and practice of plant hormones analyses. Academic Press : London. Biological Techniques Series, 2 Vol, 401 pp.
39. M. Roulet, R. Laurini and L. Rivier (1988) Hepatic veno-occlusive disease in a
newborn infant of a woman drinking herbal tea. J. of Pediatrics112, 433 - 436.
40. Ch. Benedek and L. Rivier (1989) Evidence for the presence of tetrodotoxin in a
powder used in Haiti for zombification. Toxicon, 27, 475 - 482.
41. L. Rivier and Ch. Benedek (1989) Detection of Tetrodotoxin in an ethnic preparation. Proceedings of the TIAFT meeting, University Press : Groningen. D.R.A. Uges and R.A. de Zeeuw (Edts.), 480-490.
42. L. Rivier and M. Saugy (1989) Alcohol oxidase enzyme sensor for blood ethanol
determinations. Proceedings of the TIAFT meeting, University Press : Groningen. D.R.A. Uges and R.A. de Zeeuw (Edts.), 491-498.
43. P.A.G.M. de Smet and L. Rivier (1989) A general outlook on ethnopharmacology . Journal of Ethnopharmacology 25, 127-138.
44. M. Saugy and L. Rivier (1990) GC-MS quantifications of free and ester indol-3yl-
acetic acids in relation to root growth and gravitropism. R.P. Pharis et S.B. Rood (Edts.), Proceedings of the 13th International Conference on Plant Growth Substances 1988, Calgary, Springer : Berlin, Heidelberg, New York, 441-449.
45. D. Wyss, L. Rivier, HR. Gujer, F. Paccaud, P. Magnenat and B. Yersin (1990)
Characteristics of 167 consecutive traffic accident victims with special reference to alcohol intoxication : a prospective emergency room study. Soz Preventivmed35, 89- 93.
46. Ph. Meuwly, A. Munafo, L. Rivier and M. Saugy (1991) Rapid high-performance
liquid chromatographic determination with fluorescence detection of furosemide in human body fluids and its confirmation by gas chromatography-mass spectrometry. J. Chromatography B564, 567-578 .
47. L. Rivier , C. Giroud et C. Staub. (1991) Caractérisation de la prise d'opiacés (héroïne,
morphine, codéine et éthylmorphine) par l'intermédiaire de l'analyse d'urine : quels critères adopter ?. Praxis, Revue suisse de Médecine80, 1135-1139.
48. R. Anton and L. Rivier (1991) Introduction to "Ethnopharmacology 1990" :
Proceedings of the First International Congress on Ethnopharmacology, Strasbourg, France, June 1990. Journal of Ethnopharmacology32, 1-2.
49. C. Cardis, M. Saugy and L. Rivier. Diuretics in Doping Controls (1991) Caracterisation
in Human Urine by Using Gas Chromatographiy - Chemical Ionisation Mass Spectrometry. Proceedings of the TIAFT Meeting, Copenhagen, 271-285.
50. C. Giroud, C. Cardis, M. Saugy and L. Rivier (1991) Positive Urine for Doping Agents
after Receiving a Single Capsule of an Ephedra Phytotherapeutic Preparation Proceedings of the TIAFT Meeting, Copenhagen, 221-230
51. B. Yersin, D. Wyss, V. Koehn, L. Rivier, HR Gujer, F. Paccaud and P. Magnenat
(1992) Detrimental effect of accute alcohol intoxication on severity of non-fatal
injuries in male traffic accident victims : a cross-sectional study. Soz. Praeventivmed. 37, 118-123.
52. L. Rivier, M. Saugy and E. Levaine-Horvath. (1992) Is Computerized GC-MS Useful
for the Detection of Benzodiazepines in Forensic Cases ? In "Forensic Toxicology", John S. Oliver (Edt.) Edinburgh : Scottish Academic Press, 196-202.
53. E. Horvath and L. Rivier (1992) Chloral Hydrate, a 100 years old toxic drug still of
actiality. In "Forensic Toxicology", John S. Oliver (Edt.) Edinburgh : Scottish Academic Press, 235-239.
54. D. Cantoni and L. Rivier. (1992) Analysis of the secretions from the flank glands of 3
shrews species and their possible functions as a social context. In "Chemical Signals in Vertebrates VI", R.L. Doty and D. Müller-Schwarze (Edts.), New York : Plenum Press, 99-106.
55. E. Roulet Perez, P. Maeder, L. Rivier and T. Deonna (1992) Toxic
Leucoencephalopathy after heroin ingestion in a 2 1/2 year old Child. Lancet 340, 729.
56. L. Rivier (1992) Détection de la toxicomanie : sur la trace de 100 stupéfiants. UNI- Lausanne72, 51-52.
57. M. Saugy and L. Rivier (1992) Sport de haut niveau : la Suisse a son laboratoire anti-
dopage. UNI-Lausanne72, 53-55.
58. M. Saugy, C. Cardis, L. Rivier et G.-A. Carrel (1993) Hormone de croissance : LUC
volley-ball, équipe témoin, UNI-Lausanne, spécial sports, 46-49.
59. C. Cardis, M. Saugy et L. Rivier (1993) L'Unité d'Analyse du Dopage (UAD) de
l'Université de Lausanne. Bilan des premiers mois d'activité, UNI-Lausanne, spécial sports, 50-51.
60. C. Giroud, T. Colassis, L. Rivier et E. Ottinger (1993) Cocaïne et alcool : un cocktail
explosif !, Praxis15, 441-446.
61. C. Giroud, M. Saugy, T. Colassis and L. Rivier (1993) What criteria should be used
for forensic drug testing of alkyl-morphines ? dans Nagata T., ed, Proceedings of the 30th international meeting of the International Association of Forensic toxicologists (TIAFT), Yoyodo Printing Kaisha Ltd, Fukuoka, Japan,. 329-333.
62. L. Rivier (1994) Ethnopharmacology of LSD and related compounds. In "5o years of LSD : states of the art and perspectives of hallucinogens". Swiss Academy of Medical Sciences (Edt.) : Basel, Parthenon Publ. : Carnforth, 43-56.
63. M. Augsburger and L. Rivier. (1994) Drug screening in whole blood sample by
automated extractive dialysis and gas chromatography. Toxicorama4, 23-32,.
64. M. Augsburger, C. Giroud, P. Lucchini and L. Rivier (1994) Suicide involving
zolpidem and hypothermia. In : Contributions to Forensic Toxicology. R. K. Muller (Edt.) Molinapress : Leipzig, 18-22.
65. M. Augsburger et L. Rivier (1994) Recherche de drogues et médicaments dans le sang
par dialyse extractive automatisée et chromatographie en phase gazeuse. Toxicorama4 , 23-32.
66. C. Giroud, T. Colassis and L. Rivier (1994) Forensic screening of cocaine, ethylcocaine
and their respective metabolites in blood and urine from drug abusers in Switzerland. Toxicorama6, 19-29.
67. C. Grunauer, M. Saugy and L. Rivier (1994) Direct Extractive Methylation and
Automatic GC-MS Screening and Identification of Drugs of Abuse and Other Compounds of Potential Abuse in Sport. Proceedings of the 31st international meeting of the International Association of Forensic toxicologists (TIAFT), Leipzig : MOLINApress , 419-422.
68. L. Rivier, M. Saugy and M. Augsburger (1994) Automated Dialysis : a new approach
to prepare blood samples for systematic drug analysis in forensic and doping controls. Blood samples in doping control. Second International Symposium on drugs in Sports - Lillehammer 1993, Pensumtjeneste (On Demand Publishing), Oslo, 165- 172.
69. M. Saugy, C. Cardis, M. Caron, F. Gomez, S. Landolt and L. Rivier (1994) Urinary
human growth hormone (U-HGH) : Alternative to hGH blood test in doping controls ? Blood samples in doping control. Second International Symposium on drugs in Sports - Lillehammer 1993, Pensumtjeneste (On Demand Publishing), Oslo, 53-64.
70. C. Giroud, A. Sutter, M. Augsburger and L. Rivier (1995) Fatal strychnine self-
poisonning in hospital. In : Advances in Forensic Sciences Vol. 5. Jacob B. et Bonte W. (Edts.) Köster : Berlin , 108-111.
71. C. Giroud, M. Augsburger and L. Rivier (1995) The Tradegy of the sect of the "Ordre
du Temple Solaire" (Cheiry-Salvan, Switzerland, 48 deaths) : Analytical strategy and main toxicological findings. In : Aspects on Forensic Toxicology. Kovatsis A.V. et Tsoukali-Papadopoulou H. (Edts) Erasmos : Thessaloniki, 243-248.
72. C. Giroud, P. Lucchini and L. Rivier (1995) An Intoplicine Fatality. In : Bridging the World of Forensic Toxicology. V. Spiehler (Edt.) Proceedings of the 1994 SOFT- TIAFT international symposium, Tampa, U.S.A., 113-120.
73. L. Rivier, M. Saugy and C. Cardis (1995) Endogenous doping agents detection : State-
of-the-art and new strategies as demonstrated by the growth hormone problem. In : Aspects on Forensic Toxicology. Kovatsis A.V. et Tsoukali-Papadopoulou H. (Edts) Erasmos : Thessaloniki,. 83-87.
74. L. Rivier and M. Saugy (1995). Systematic Drug Identification. in "Encyclopedia of Analytical Science". Academic Press : London, 1594-1606. 75. L. Rivier (1995)Conduite automobile et Toxicomanie en Suisse. Actes du Symposium STRATOX II. A. Traqui (Edt.). Strasbourg : IUML, 161-169.
76. C. Giroud, M. Augsburger, Guignard N., Mahdad A., Proccureur A, Steiger C et L.
Rivier (1995) Les 48 victimes du drame de la secte de l’Ordre du Temple Solaire : notre stratégie pour l’analyse toxicologique systématique. Actes du Symposium STRATOX II, A. Traqui (Edt.). Strasbourg : IUML, 243-248.
77. L. Rivier, M. Saugy and A. Sutter (1995) Forensic actuality of anabolic steroid
violence and addiction. In : Bridging the World of Forensic Toxicology. V. Spiehler (Edt.) Proceedings of the 1994 SOFT-TIAFT international symposium, Tampa, U.S.A., 292-301.
78. M. Saugy, C. Cardis and L. Rivier (1995) Urinary human growth hormone (U-hGH) I.
Measurements in non-athlete volunteers after intra-muscular or subcutaneous hGH injections. In : Recent Advances in Doping Analysis Vol. 2, M. Donike, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss, 213-222.
79. M. Saugy, C. Cardis, L. Rivier, G. Brisson., C. Ayotte, P. Hemmersbach, E. Haug and
J. Segura (1995) Urinary human growth hormone (U-hGH) II. Measurements in competition tests . More the expression of the renal function than the endocrinological status. In : Recent Advances in Doping Analysis Vol. 2, M. Donike, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss , 223-234.
80. C. Giroud et L. Rivier (1995) Problèmes médico-légaux posés par la commercialisation
de l’huile de chanvre en Suisse. Toxicorama7, 15-23.
81. C. Giroud, W. Eichenberger and L. Rivier (1995) Hemp seed oil : a new source of
edible oil for Switzerland ? Biol. Chem. Hoppe-Seyler376, S52.
82. C. Giroud and L. Rivier (1996) Characterization of different "Swiss" Hemp exhibits
with regard to their Cannabinoid Content. TIAFT Bulletin26, 30-34.
83. M. Saugy, C. Cardis, C. Schweizer, N. Dimo-Simonin, F. Grange, C. Brandt-
Casadevall and L. Rivier (1996) Identification problems of urine samples in doping controls resolved by DNA-PCR.In : Recent Advances in Doping Analysis Vol. 3, M. Donike, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss 337-347.
84. M. Saugy, C. Cardis, C. Schweizer, J.-L. Veuthey and L. Rivier (1996) The detection
of human growth hormone doping in urine : Out of competition tests are necessary. Journal of Chromatography B687, 201-211.
85. D. Cantoni, L. Favre, F. Tencalla, P. Croset, F. Morgenthaler, G. Camarda, C. Ruchet,
L. Rivier and P. Vogel (1996) Intra- and interindividual variation in flank gland secretions of free-ranging shrews Crocidura russula. J. Chemical Ecology 22, 1669- 1688.
86. D.D. Soejarto, L. Rivier, C. Gyllenhaal and N.R. Farnsworth (Edts.) (1996)
Intellectual property rights, naturally derived bioactive compounds and resourceconservation. Amsterdam : Elsevier Science, 336 pp.
87. M. Augsburger and L. Rivier (1997) Drugs and alcohol among suspected impared
drivers in Canton de Vaud (Switzerland). Forensic Science International85, 95-107.
88. F. Sadeghipour, E. Varesio, C. Giroud, L. Rivier and J.-L. Veuthey (1997) Analysis of
Amphetamines by Capillary Electrophoresis and Liquid Chromatography - Application to Drug Seizures and Cross-validation. Forensic Science International86, 1-13.
89. C. Giroud, M. Augsburger, F. Sadeghhipour, E. Varesio, J.-L. Veuthey et L. Rivier
(1997) Ecstasy - La situation en Suisse romande. Praxis 86, 510-523.
90. F. Sadeghipour, C. Giroud, L. Rivier and J.-L. Veuthey (1997) Rapid determination of
amphetamines by high-performance liquid chromatography with UV detection. J. Chromatogr. A761, 71-78.
91. C. Giroud, M. Augsburger, F. Sadeghipour, E. Varesio, J.-L. Veuthey, L. Rivier et P.
Mangin (1997) Ecstasy and « raves » en Suisse romande. Toxicorama 9, 113-122.
92. L. Rivier (1997) Between gastronomy and sorcery : the ethnotoxicological role of
tetrodotoxin. In : Healing yesterday and today, tomorrow ? Pproceedings of the 1stInternational conference of anthropology and history of health and disease. A. Guerci(Edt.), CD-Rom and printed form. Erga multimedia, 3 pages
93. L. Rivier (1997) Activities of the unit for forensic chemistry and toxicology of the
Swiss society of legal medicine. Chimia 51, 780-781.
94. C. Schweizer, C. Cardis, M. Cauderay, L. Rivier and M. Saugy (1997) T/E ratio
variations through puberty in male adolescents. In : Recent Advances in Doping Analysis Vol. 4. , W. Schänzer, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss , 159-171.
95. C. Cardis, C. Schweizer, M. Saugy and L. Rivier (1997) Ketoconazol test : blood
versus urine values. In : Recent Advances in Doping Analysis Vol. 4. , W. Schänzer, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss , 305-317.
96. A. Durussel, C. Cardis, C. Schweizer, L. Rivier, G. Brisson and M. Saugy (1997)
Influence of creatine intake upon biochemical parameters in urine. In : Recent Advances in Doping Analysis Vol. 4. , W. Schänzer, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss , 323-333.
97. M. Augsburger, C. Giroud, L. Rivier and P. Mangin (1997) Analytical strategy for
analysis of drugs in biological samples in case of DUID. In : Alcohol, Drugs and Trafic Safety - T’973, 1421-1426.
98. L. Rivier, M. Augsburger et P. Mangin (1997) Les drogues détectées chez 641
conducteurs suspectés d’incapacité à conduire : nature des substances et incidence des interactions. J. Médecine légale et Droit médical40, 601-605.
99. C. Giroud, M. Augsburger, B. Horisberger, P. Lucchini, L. Rivier et P. Mangin (1997)
Suicide assisté par l’association „EXIT“ : aspects toxicologiques et médico-légaux. Toxicorama Numéro spécial, 359-362.
100. M. Augsburger, C. Giroud, L. Rivier, A. Traqui and P. Mangin (1998) Car crash after
massive ingestion of digoxin and midazolam. Intern. J. Legal Medicine111, 205-207.
101. C. Giroud, M. Augsburger, L. Rivier and P. Mangin (1998) Hemp tea versus hemp
milk : subjective effects and elimination studies of THC and its main metabolites. Proceedings of the 35th international meeting of the International Association of Forensic toxicologists (TIAFT), Cleub : Padova, Italy, 112-121.
102. L. Rivier (1998) The use of high selectivity MS techniques to increase the
retrospectibility of the detection of the abuse of selected doping agents. Proceedings of the 35th international meeting of the International Association of Forensic toxicologists (TIAFT), Cleub : Padova, Italy, 191-198.
103. M. Augsburger, L. Rivier and P. Mangin (1998) Comparison of different
immunoassays and GC-MS screening of benzodiazepines in urine. J. Pharmaceutical and biomedical analysis18, 681-687.
104. C. Giroud, M. Augsburger, L. Rivier, P. Mangin, F. Sadeghipour, E. Varesio, J.-L.
Veuthey and P. Kamalaprija (1998) 2C-B : A new psychoactive phenylethylamine recently discovered in ecstasy tablets sold on the Swiss black market. J. Analytical Toxicology22, 345-354.
105. C. Schweizer, C. Cardis, M. Saugy and L. Rivier (1998) Nicotine in sports : use and
abuse. In : Recent Advances in Doping Analysis Vol. 5. , W. Schänzer, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss , 269-277.
106. C. Giroud, A. Broillet, M. Augsburger, W. Bernhard, L. Rivier et P. Mangin (1999)
Bref historique de la culture récente du chanvre en Suisse et problèmes médico-légaux engendrés par cette culture. Praxis 88, 113-122.
107. C. Giroud, A. Broillet, M. Augsburger, A. Ménétrey, W. Bernhard, L. Rivier and P.
Mangin (1999) “Cannabis sativa ssp. Helvetica” or the serial thriller of hemp in Switzerland. Toxicorama11, 51-58.
108. C. Giroud, M. Augsburger, B. Horisberger, P. Lucchini, L. Rivier and P. Mangin
(1999) Exit association - mediated suicide : Toxicologic and forensic aspects. Am. J. Forensic Medicine and Pathology20, 40-44.
109. A. Dienes-Nagy, L. Rivier, C. Giroud, M. Augsburger and P. Mangin (1999) Method
for auntification of morphine and its 3- and 6-glucuronides, codeine, codeine glucuronide and 6-mono-acetylmorphine in human blood by liquid chromatography- electrospray mass spectrometry for routine analysis in forensic toxicology. J. Chromatogr. A854, 109-118.
110. N. Robinson, C. Cardis, A. Dienes, C. Schweizer, M. Saugy and L. Rivier (1999)
Immunoaffinity chromatography combined with ion trap technique in order to detect traces of 19-norandrosterone. In : Recent Advances in Doping Analysis Vol. 6. , W. Schänzer, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss, 131-143.
111. C. Schweizer, , C. Cardis, M. Cauderay, L. Rivier and M. Saugy (1999) Profile
variations through puberty in young adolescent girls. In : Recent Advances in Doping Analysis Vol. 6. , W. Schänzer, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.),Köln : Verlag Sport und Buch Strauss, 205-221.
112. L. Rivier and M. Saugy (1999) Peptide hormones abuse in sport : State of the art in
the detection of growth hormone and erythropoietin. J. Toxicol. - Toxin reviews 18, 145-176.
113. L. Rivier (1999) Une zone grise dans le dopage des sportifs : les substances
ergogènes. Médecine et Hygiène57, 2034-2041.
114. L. Rivier (1999) Possibilities and restraints of the doping laboratory. Proceedings of the 6th congress of equine medicine and surgery, P. Chuit (Edt.), Geneva, 56-62
115. M. Saugy, N. Robinson, C. Cardis, C. Schweizer, L. Rivier, P. Mangin, C. Ayotte
and J. Dvorak (1999) Nandrolone metabolites in football players : Utility for in and out of competition tests. In : Recent Advances in Doping Analysis Vol. 7. , W. Schänzer, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss , 95-108.
116. C. Giroud, F. Felber, M. Augsburger, B. Horisberger, L. Rivier and P. Mangin
(1999) Salvia divinorum Epling and Jativa, a vision-inducing mint recently discovered in Switzerland. TIAFT Bulletin 29, 19-20.
117. C. Giroud, F. Felber, M. Augsburger, B. Horisberger, L. Rivier and P. Mangin
(1999) Salvia divinorum : an hallucinogenic mint which might become a new recreational drug in Switzerland. Forensic Science International 112, 143-150.
118. L. Rivier et P. Mangin (1999) Principaux produits dopants et leurs effets secondaires.
Une compilation préparée pour le compte de l’Union cycliste internationale. Lausanne: UCI, 35 pages (traduit en anglais, allemand, japonais et hongrois).
119. L. Rivier et P. Mangin (1999) Techniques for analytical testing in sport doping with
unconventional samples. Une expertise préparée à l’attention de l’Office fédéral dessports, Macolin, 20 pages.
120. L. Rivier (2000) Is there a place for hair analysis in doping controls ? Forensic Science International107, 309-323.
121. L. Rivier (2000) Doping testing on alternative biological matrixes. Biology of Sport 17, 87-106.
122. L. Rivier (2000) Les produits dopants de demain. Annales de Toxicologie analytique 12, 79-89.
123. L. Rivier (2000) Techniques for analytical testing of unconventional samples. In
“Baillière’s Best Practice and research in clinical endocrinology and metabolism (Special issue on Doping in Sport, P.E. Mullis, Guest Editor) 14, 147-165.
124. L. Rivier, C. Cardis and P. Mangin (2000) Equine Drug Testing. Encyclopedia of Toxicology, Academic Press, 6 pages.
125. L. Rivier (2000) Editorial. J. Ethnopharmacol. 73, iii
126. O. Beck et L. Rivier (2000) European urine drug testing contrast with U.S. practices. Clinical & Forensic Toxicology News June, 1, 4-5.
127. M. Kamber, N. Baume, M. Saugy et L. Rivier (2001) Nutritional supplements as a
source for positive doping cases ? J. Sport Nutr. & Exercise Metabolism, 11, 258 - 263.
128. L. Rivier et P. Mangin (accepted for publication 2001) Le dépistage analytique
systématique en laboratoire du dopage sportif au moyen de matrices biologiques alternatives à l’urine. Revue Médecine du sport, 15 pages
129. K. Fluri, L. Rivier, A. Dienes-Nagy, C. You, A. Maître, C. Schweizer, M. Saugy et
P. Mangin (2001) Method for confirmation of synthetic corticosteroids in doping urine samples by liquid chromatography - electrospray ionisation mass spectrometry. J. Chromatogr. A. 926, 87-95.
130. H. Hilleret, P. Voirol, Ph. Bovier, P. Giannakopoulos, D. Zullino, P. Baumann, Ch.
Giroud, L. Rivier et Ch. B. Eap (2002) Very long Half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizer : A case report. Therapeutic Drug Monit. In press.
131. L. Rivier (2002) New trends in doping analysis. Chimia (in press) 12 pp.
132. L. Rivier (sumitted) Laboratory technology. In “Medico-legal of drugs” M. Burns
133. L. Rivier, T. Mellingsaeter and E. Jensen (in preparation) Detection of
Perfluorocarbones by Head Space Gas Chromatography - Mass Spectrometry in Blood Samples. J. Analytical Toxicology.
134. L. Rivier (in preparation) Fiabilité des tests de dépistage de la consommation de
drogues chez les adolescents. Praxis.
WAYNE STATE UNIVERSITY LOSS EXPERIENCE Claims Paid as of 12/31/2011 2008/2009 Policy Year Ultimate with Claims Paid Ultimate Loss Ratio Domestic International 2009/2010 Policy Year Ultimate with Claims Paid Ultimate Loss Ratio Domestic International 2010/2011 Policy Year Ultimate with Claims Paid Ultimate Loss Ratio Domestic
INTERNAL AUDIT CHARTER INTRODUCTION Management and the Audit Committee believe that a professional, independent Internal Audit Services Department is essential to the most economical, effective and efficient operation of the Company. The purpose of this charter is to establish the Internal Auditing function within the organization, authorize its access to records, personnel, and phys